Herbal

Apigenin

Also known as: 4',5,7-trihydroxyflavone, apigenol, apiin (glycoside form)

Overview

Apigenin is a flavonoid found in various plants, including parsley, celery, and chamomile, and has been studied for its potential antioxidant, anti-inflammatory, and anticancer properties. Preclinical studies suggest that apigenin may modulate signaling pathways involved in cell proliferation, apoptosis, and inflammation, supporting its investigation as a chemopreventive agent [7]. However, clinical evidence in humans remains limited, with no robust randomized controlled trials establishing efficacy for any specific health condition. While flavonoids like apigenin are generally considered safe when consumed in dietary amounts, the potential for toxicity with high-dose supplementation has not been fully evaluated, and concerns about product standardization and regulatory oversight remain [1][2]. Further clinical development of apigenin as a dietary supplement requires rigorous phase II dose-finding and safety studies before larger phase III trials can be justified [8].

Dosage Guide

Therapeutic Doses

For treatment of specific conditions

General antioxidant/anti-inflammatory support50-100 mg/dayBased on preclinical models and limited human data; optimal dose not established

Upper Intake Limit

Maximum safe daily intake

mgNo established tolerable upper intake level; safety of long-term high-dose supplementation unknown

Special Forms

Alternative forms for specific needs

Apigenin-7-O-glucoside (apiin)

More water-soluble form found in parsley and chamomile; may have altered bioavailability

Clinical Notes

  • Limited human safety data exist for high-dose apigenin supplementation; potential for unknown toxicities with long-term use.
  • Apigenin may interact with cytochrome P450 enzymes and drug metabolism; caution with concurrent medication use.
  • Due to lack of standardization in supplements, product potency and purity may vary significantly between brands.

Research

Key FindingsPubMed
1

Flavonoids, including apigenin, have potential toxicity that is understudied, despite their widespread use in dietary supplements.

[Advances in studies on potential toxicity of flavonoids].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica2006
2

Clinical trials of herbal treatments face challenges including lack of standardization and difficulty in blinding, limiting evidence quality.

Clinical trials of herbal treatments.
Evaluation & the health professions2009
3

Dietary supplements for conditions like erectile dysfunction lack adequate clinical trial data to confirm benefits beyond placebo.

Dietary supplements and other alternative medicines for erectile dysfunction. What do I tell my patients?
The Urologic clinics of North America2002
4

Scientific validity of many commercial natural compounds is limited by poor quality control and lack of regulatory oversight.

Bioactive natural compounds for the treatment of gastrointestinal disorders.
Clinical science (London, England : 1979)2003
5

Herbal supplements lack evidence for liver disease treatment but show some promise for functional gastrointestinal symptoms.

Herbal supplements.
Current gastroenterology reports2005
6

80 mg/day of purified isoflavones was safe over 12 weeks in men with prostate cancer, suggesting safety of certain flavonoid-like compounds at pharmacologic doses.

Safety of purified isoflavones in men with clinically localized prostate cancer.
Nutrition and cancer2007
7

Preclinical data support chemopreventive potential of natural agents like apigenin, with few side effects reported in long-term use.

Natural agents in the prevention of cancer, part two: preclinical data and chemoprevention for common cancers.
Alternative medicine review : a journal of clinical therapeutic2001
8

Phase II dose-finding studies should precede phase III trials for dietary supplements to ensure efficacy and optimal dosing.

Clinical development of dietary supplements: the perils of starting at phase III.
Fitoterapia2011

Products Containing Apigenin(2 reports)